SCHEMBL418194

SCHEMBL418194

CC(=O)OCCCCCCCCCC(C)C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
PTPN1 P18031 1/20 0.45
LMNA P02545 3/20 0.43
APOBEC3A P31941 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 3/20 0.40
CHRM5 P08912 2/20 0.40
CHRM1 P11229 2/20 0.40
CHRM3 P20309 2/20 0.40
RARB P10826 1/20 0.40
PGR P06401 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
HTR1A P08908 1/20 0.40
CHRNB2 P17787 1/20 0.40
TBXA2R P21731 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA7 P36544 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27984991 1.00 ALDH1A1 (0.52) ALDH1A1PTPN1LMNAAPOBEC3AAPOBEC3G
SCHEMBL28463752 1.00 ALDH1A1 (0.52) ALDH1A1PTPN1LMNAAPOBEC3AAPOBEC3G
SCHEMBL333496 1.00 ALDH1A1 (0.52) ALDH1A1PTPN1LMNAAPOBEC3AAPOBEC3G
SCHEMBL27261222 1.00 ALDH1A1 (0.52) ALDH1A1PTPN1LMNAAPOBEC3AAPOBEC3G
SCHEMBL421572 1.00 ALDH1A1 (0.52) ALDH1A1PTPN1LMNAAPOBEC3AAPOBEC3G
SCHEMBL30638779 1.00 ALDH1A1 (0.52) ALDH1A1PTPN1LMNAAPOBEC3AAPOBEC3G
SCHEMBL8772844 1.00 ALDH1A1 (0.52) ALDH1A1PTPN1LMNAAPOBEC3AAPOBEC3G
SCHEMBL757134 1.00 ALDH1A1 (0.52) ALDH1A1PTPN1LMNAAPOBEC3AAPOBEC3G
SCHEMBL2120826 1.00 ALDH1A1 (0.52) ALDH1A1PTPN1LMNAAPOBEC3AAPOBEC3G
SCHEMBL28151807 0.98 ALDH1A1 (0.50) ALDH1A1PTPN1LMNAAPOBEC3AAPOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006071439-A1 METHOD OF MAKING AND USING INKJET INKS 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-07-06 WO claimed
US-20060142415-A1 Method of making and using inkjet inks 3M INNOVATIVE PROPERTIES COMPANY 2006-06-29 US claimed
US-12559624-B2 Film comprising polylactic acid polymer suitable for graphic articles 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-02-24 US disclosed
EP-3541881-B1 FLEXIBLE HARDCOAT COMPRISING URETHANE OLIGOMER HYDROGEN BONDED TO AN ACRYLIC POLYMER 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-02-18 EP disclosed
US-12404419-B2 Imide addition-fragmentation agents 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-09-02 US disclosed
US-12398301-B2 Adhesives comprising cyclic imide addition-fragmentation and adhesion agents 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-08-26 US disclosed
US-20250179328-A1 THERMOFORMABLE PAINT FILMS 3M INNOVATIVE PROPERTIES COMPANY 2025-06-05 US disclosed
US-20250011633-A1 Adhesives Comprising Cyclic Imide Addition-Fragmentation And Adhesion Agents 3M INNOVATIVE PROPERTIES COMPANY 2025-01-09 US disclosed
EP-4444809-A1 ADHESIVES COMPRISING CYCLIC IMIDE ADDITION-FRAGMENTATION AND ADHESION AGENTS 3M Innovative Properties Company (US) 2024-10-16 EP disclosed
US-20240294748-A1 FILM COMPRISING POLYLACTIC ACID POLYMER SUITABLE FOR GRAPHIC ARTICLES 3M INNOVATIVE PROPERTIES COMPANY (US) 2024-09-05 US disclosed
EP-4402189-A1 THERMOFORMABLE PAINT FILMS 3M Innovative Properties Company (US) 2024-07-24 EP disclosed
US-20030021961-A1 SHEET COMPRISING SUPPORT AND INK RECEIVING LAYER COMPRISING BINDER SELECTED FROM GELATIN AND GELATIN DERIVATIVES AND SACCHARIDE SELECTED FROM MONO-, OLIGO-, OR POLY-SACCHARIDES OBTAINED BY ENZYMATIC PROCESSING OF NATURAL POLYSACCHARIDES 3M INNOVATIVE PROPERTIES COMPANY 2003-01-30 US disclosed
WO-2003002353-A1 IMAGED ARTICLES COMPRISING A SUBSTRATE HAVING A PRIMED SURFACE 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-01-09 WO disclosed
WO-2002085638-A1 PRIMED SUBSTRATES COMPRISING RADIATION CURED INK JETTED IMAGES 3M INNOVATIVE PROPERTIES COMPANY (US) 2002-10-31 WO disclosed
US-6467897-B1 Energy curable inks and other compositions incorporating surface modified, nanometer-sized particles 3M INNOVATIVE PROPERTIES COMPANY 2002-10-22 US disclosed
US-20020149659-A1 ENERGY CURABLE INKS AND OTHER COMPOSITIONS INCORPORATING SURFACE MODIFIED, NANOMETER-SIZED PARTICLES 3M INNOVATIVE PROPERTIES COMPANY 2002-10-17 US disclosed
WO-2002053659-A2 ENERGY CURABLE INKS AND OTHER COMPOSITIONS INCORPORATING SURFACE MODIFIED, NANOMETER-SIZED PARTICLES 3M INNOVATIVE PROPERTIES COMPANY (US) 2002-07-11 WO disclosed
US-20020086914-A1 Comprising an oligo/resin, a radiation curable reactive diluent of an adhesion-promoting, heterocyclic, radiation curable monomer and/or an alkoxylated acrylic ester; solvent-free; low viscosity; durable, abrasion resistant 3M INNOVATIVE PROPERTIES COMPANY 2002-07-04 US disclosed
WO-2002038687-A1 INKS AND OTHER COMPOSITIONS INCORPORATING LIMITED QUANTITIES OF SOLVENT ADVANTAGEOUSLY USED IN INK JETTING APPLICATIONS 3M INNOVATIVE PROPERTIES COMPANY (US) 2002-05-16 WO disclosed
WO-2002038688-A2 WEATHER RESISTANT, INK JETTABLE, RADIATION CURABLE, FLUID COMPOSITIONS PARTICULARLY SUITABLE FOR OUTDOOR APPLICATIONS 3M INNOVATIVE PROPERTIES COMPANY (US) 2002-05-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559624-B2 Film comprising polylactic acid polymer suitable for graphic articles POT1, PARG, TCP1 ALDH1A1 373/4885PTPN1 454/4885LMNA 1369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.